Olema Pharmaceuticals, Inc. (NASDAQ: OLMA ) is a developmental pharmaceutical company working on treatment options for breast cancer in different settings, most notably the most common molecular subtype. The company is deep in late-stage clinical trialsI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligenc ...